Immune evasion before tumour invasion in early lung squamous carcinogenesis
…, A Haller, V Ninane, A Burny, JP Sculier, A Spira… - Nature, 2019 - nature.com
Early detection and treatment are critical for improving the outcome of patients with cancer 1
. Understanding the largely uncharted biology of carcinogenesis requires deciphering …
. Understanding the largely uncharted biology of carcinogenesis requires deciphering …
Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines
Induced pluripotent stem cells (iPSCs) hold great promise for modeling human hematopoietic
diseases. However, intrinsic variability in the capacities of different iPSC lines for …
diseases. However, intrinsic variability in the capacities of different iPSC lines for …
[HTML][HTML] Susceptibility to chronic mucus hypersecretion, a genome wide association study
…, M Dahlback, K Tosh, PS Hiemstra, PJ Sterk, A Spira… - PloS one, 2014 - journals.plos.org
Background Chronic mucus hypersecretion (CMH) is associated with an increased frequency
of respiratory infections, excess lung function decline, and increased hospitalisation and …
of respiratory infections, excess lung function decline, and increased hospitalisation and …
A nasal clinical-genomic classifier for assessing risk of malignancy in lung nodules demonstrates accurate performance independent of nodule size or cancer stage
…, S Bhorade, W Bulman, L Lofaro, J Huang, A Spira… - Chest, 2021 - journal.chestnet.org
PURPOSE: Accurate assessment of the risk of malignancy (ROM) is critical in the management
of a screen-detected or incidental pulmonary nodule (PN) to minimize procedures for …
of a screen-detected or incidental pulmonary nodule (PN) to minimize procedures for …
Pioglitazone as a candidate chemoprevention agent for lung cancer: A pilot window trial in early stage NSCLC.
…, Y Gesthalter, P Holland, MC Aubry, PJ Limburg, S Avi… - 2014 - ascopubs.org
1581 Background: Multiple lines of evidence support the use of PPARγ ligands in the treatment
and prevention of lung cancer. Pioglitazone is a PPARγ ligand that is FDA-approved for …
and prevention of lung cancer. Pioglitazone is a PPARγ ligand that is FDA-approved for …
[HTML][HTML] A simple assessment of lung nodule location for reduction in unnecessary invasive procedures
Background CT screening for lung cancer results in a significant mortality reduction but is
complicated by invasive procedures performed for evaluation of the many detected benign …
complicated by invasive procedures performed for evaluation of the many detected benign …
Characterizing the T cell repertoire in lung squamous cell premalignancy and its association with lesion outcome.
…, SS Dhillon, C Stevenson, ME Reid, M Lenburg, S Avi… - 2019 - ascopubs.org
102 Background: The immune response to frank malignancy has been the focus of published
work, but little is known about the adaptive immune response to bronchial premalignant …
work, but little is known about the adaptive immune response to bronchial premalignant …
microRNA profiling in pulmonary fibroblasts in COPD
…, J Campbell, M Jonker, M Lenburg, A Spira… - 2011 - Eur Respiratory Soc
COPD is characterized by emphysema with loss of extracellular matrix (ECM), and (small)
airways disease with increased ECM deposition and airway wall thickening. How both …
airways disease with increased ECM deposition and airway wall thickening. How both …
Jurisprudence Review
…, T LIU, P PARK, T RICE, D SALMON, AVI SPIRA… - journals.library.wustl.edu
… DAUGS SAMUAL GARNER THEANNE LIU PAISLEY PARK TATIANA RICE DANIEL
SALMON AVI SPIRA JOSHUA WASBIN …
SALMON AVI SPIRA JOSHUA WASBIN …
[HTML][HTML] Bronchial epithelial gene expression and interstitial lung abnormalities
AA Menon, M Lee, X Ke, RK Putman, T Hino… - Respiratory …, 2023 - Springer
Introduction Interstitial lung abnormalities (ILA) often represent early fibrotic changes that
can portend a progressive fibrotic phenotype. In particular, the fibrotic subtype of ILA is …
can portend a progressive fibrotic phenotype. In particular, the fibrotic subtype of ILA is …